Walker to support corporate strategic development following the launch of Kailos, a consumer-directed gene-based test

Huntsville, ALABAMA – July 27, 2015Kailos Genetics, a personalized medicine information company offering leading-edge gene-based testing, today announced the expansion of its senior management team through the addition of experienced life science industry veteran Cheri Walker, PhD as chief financial officer and senior vice president of corporate development.

With more than 18 years of experience in the life science and diagnostic market, Dr. Walker will support Kailos Genetics with a strong combination of technical and financial skills. She will draw on expertise gained from her work as an equity analyst for Deutsche Bank and through senior level corporate development and operating roles at Invitrogen, QIAGEN and Charles River Labs. Dr. Walker also served on the board of directors of Diatherix Laboratories, Inc. and has a PhD from Baylor College of Medicine in Human and Molecular Genetics with a BA in Biology from Swarthmore College.

“We are pleased to announce the addition of Cheri to our team. She brings an arsenal of experience and connections in the life science tools and diagnostic market that will help us position our organization as the leading provider of affordable and accessible genetic testing,” said Brian Pollock, president and CEO of Kailos Genetics. “It’s a critical time for Kailos to introduce a strategic financial leader as we enter into our next phase of growth. With the launch of Kailos, our consumer-directed gene-based test and a strong pipeline of new offerings coming to market—including a test for breast and ovarian cancer susceptibility this fall—we are confident that Cheri’s strong leadership will help drive continued strategic growth and expansion.”

The appointment of Dr. Walker follows Kailos Genetics’ release of Kailos as part of their new business model based on providing consumers with affordable and accessible genetic testing.

“I’ve been advising Kailos on business strategy over the last several years and am excited to be joining the team as CFO,” said Dr. Walker. “I share in the company’s vision to provide consumers, their families and their physicians with access to genetic information so that they are able to make vital healthcare decisions and in turn, lead happier, healthier lives.”

With the addition of Dr. Walker to the leadership team, Kailos Genetics looks forward to expanding their offerings and educating consumers on the benefits of genetic testing.

About Kailos

Kailos Genetics is a trusted provider of personalized health information. Addressing unmet needs of healthcare consumers and their families is Kailos’ primary reason for being. With its proprietary and robust DNA sequencing enrichment and laboratory information system, TargetRich™, Kailos helps make personalized medicine affordable and accessible for everyone through the Kailos™ test. Founded in 2010, and based in Huntsville’s HudsonAlpha Institute for Biotechnology, Kailos is committed to providing a simple, trusted and affordable way to help individuals understand what’s in their genes. To learn more, visit www.kailoscanhelp.com/about-kailos.